Search Results - "Kimer, N."

Systematic review with meta‐analysis: the effects of rifaximin in hepatic encephalopathy by Kimer, N., Krag, A., Møller, S., Bendtsen, F., Gluud, L. L.

“…Summary Background Rifaximin is recommended for prevention of hepatic encephalopathy (HE). The effects of rifaximin on overt and minimal HE are debated. Aim To…”
Get full text

Meta-analysis: the safety and efficacy of vaptans (tolvaptan, satavaptan and lixivaptan) in cirrhosis with ascites or hyponatraemia by Dahl, E., Gluud, L. L., Kimer, N., Krag, A.

“…Summary Background Vaptans may correct hyponatraemia and mobilise ascites through an increased excretion of water. The effect on clinical outcomes is debated…”
Get full text

Rifaximin for the prevention and treatment of hepatic encephalopathy: a systematic review with meta-analyses of randomised controlled trials by Kimer, N, Gluud, L.L, Morris, R.W, Morgan, M.Y

Get full text

Umbilical hernia repair in patients with cirrhosis: systematic review of mortality and complications by Snitkjær, C., Jensen, K. K., Henriksen, N. A., Werge, M. P., Kimer, N., Gluud, L. L., Christoffersen, M. W.

“…Background Umbilical hernia is a common and potential serious condition in patients with cirrhosis. This systematic review evaluated the risks associated with…”
Get full text

The continuous reaction times method for diagnosing, grading, and monitoring minimal/covert hepatic encephalopathy by Lauridsen, M. M., Thiele, M., Kimer, N., Vilstrup, H.

“…Existing tests for minimal/covert hepatic encephalopathy (m/cHE) are time- and expertise consuming and primarily useable for research purposes. An easy-to-use,…”
Get full text

SUN-P139: Assessment of Resting Energy Expenditure in Patients with Cirrhosis Remains Problematic by Fennessy, C, Kimer, N, Morgan, M.Y

Get full text

Letter: the effects of rifaximin in hepatic encephalopathy – authors' reply by Kimer, N., Krag, A., Gluud, L. L.

Get full text

P1337 : Randomized trial with rifaximin in liver cirrhosis. Effects on the haemodynamic and inflammatory state by Kimer, N, Pedersen, J.S, Møller, S, Krag, A, Bendtsen, F

Get full text

584 NEW VASCULAR BIOMARKERS IN CIRRHOSIS: ORGAN EXTRACTION AND RELATION TO THE VASODILATORY STATE by Kimer, N, Gotze, J.P, Bendtsen, F, Moller, S

Get full text

206 RIFAXIMIN IN THE TREATMENT AND PROPHYLAXIS OF HEPATIC ENCEPHALOPATHY IN CHRONIC LIVER DISEASE: A META-ANALYSIS by Kimer, N, Gluud, L.L, Moller, S, Bendtsen, F, Krag, A

Get full text

Advances in the treatment of portal hypertension in cirrhosis by Kimer, N, Wiese, S, Mo, S, Møller, S, Bendtsen, F

“…Non-selective beta-blockers and handling of esophageal varices has been key elements in the treatment of portal hypertension in recent decades. Liver vein…”
Get more information

SAT-008 - Rifaximin for the prevention and treatment of hepatic encephalopathy: a systematic review with meta-analyses of randomised controlled trials by Kimer, N., Gluud, L.L., Morris, R.W., Morgan, M.Y.

Get full text

SAT-258 - Development and predictive validity of the cirrhosis-associated ascites symptom scale: A cohort study of 103 patients by Riedel, A., Kimer, N., Jensen, A.-S.H., Israelsen, M., Dahl, E., Aamann, L., Gluud, L.L.

Get full text

Development and predictive validity of the cirrhosis-associated ascites symptom scale: A cohort study of 103 patients by Riedel, A., Kimer, N., Jensen, A.-S.H., Israelsen, M., Dahl, E., Aamann, L., Gluud, L.L.

Get full text

Letter: vaptans for the treatment of hyponatraemia and ascites in patients with cirrhosis - authors' reply by Gluud, L. L., Dahl, E., Kimer, N., Krag, A.

Get full text

No effect of rifaximin on soluble CD163, mannose receptor or type III and IV neoepitope collagen markers in decompensated cirrhosis: Results from a randomized, placebo controlled trial by Kimer, Nina, Gudmann, Natasja Stæhr, Pedersen, Julie Steen, Møller, Søren, Nielsen, Mette Juul, Leeming, Diana Julie, Karsdal, Morten Asser, Møller, Holger Jon, Bendtsen, Flemming, Grønbæk, Henning

“…Macrophages play a significant role in chronic liver disease as reflected by elevated soluble (s)CD163 and mannose receptor (sMR) levels and associated with…”
Get full text

Safety, efficacy, and patient acceptability of rifaximin for hepatic encephalopathy by Kimer, Nina, Krag, Aleksander, Gluud, Lise L

“…Hepatic encephalopathy is a complex disease entity ranging from mild cognitive dysfunction to deep coma. Traditionally, treatment has focused on a reduction of…”
Get full text

Cameron lesions: an often overlooked cause of iron deficiency anaemia in patients with large hiatal hernias by Kimer, Nina, Schmidt, Palle Nordblad, Krag, Aleksander

“…Cameron lesions are linear gastric ulcers or erosions on the mucosal folds at the diaphragmatic impression in patients with a large hiatal hernia. The lesions…”
Get full text